PERTH, Australia, January 28 /PRNewswire/ -- Resonance Health Limited (ASX: RHT) announced today that its subsidiary, Inner Vision Biometrics Pty Ltd (IVB), has achieved U.S. Food and Drug ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

(MENAFN- ProactiveInvestors - Australia) Resonance Health's (ASX: RHT) FerriScan technology has been authorised by the U.S. Food and Drug Administration to be marketed as an imaging companion ...

FerriScan is a new technology for non-invasive measurement of liver iron concentration (LIC). It is done through magnetic resonance imaging (MRI) of a patient's liver to accurately measure the liver ...

A waste management company chaired by former Federal Health Minister Michael Wooldridge is being reinvented as a heath care company to commercialise a new liver-scanning process for early detection of ...

Resonance Health, a healthcare technology and services company, engages in the development and commercialisation of magnetic resonance imaging (MRI) related technology primarily in Australia. The ...

The Resonance Health Group (ASX: RHT) today announced that it has filed a new US patent application claiming a novel non-invasive measure of liver structure with direct application to the non-invasive ...

Claremont-based magnetic resonance imaging technology developer Resonance Health Ltd has extended the distribution deal for its liver iron monitoring device FerriScan with Switzerland-based Novartis ...